Collectively, we conclude that one of the pivotal mechanisms of action whereby 5-AcTMF exerts its anti-GBM effect is through targeted suppression of the antiapoptotic JAK2-STAT3-BCL-2/BCL-xL signaling axis. This evidence concerns the gene STAT3 and glioblastoma.